 |
 |
- Search
Search
- Page Path
-
- HOME
- Search
- Long-term Outcomes of Periurethral Sphincter Botulinum Toxin in Female Chronic Urinary Retention
- Sarah L. Wright, Piriyankan Ananthavarathan, Sara Simeoni, Prasad Malladi, Mahreen Pakzad, Jalesh N. Panicker
- Int Neurourol J. 2024;28(3):207-214. Published online 2024 September 30
-
- Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
- Hyun Seok Na, Chung Lyul Lee, Jae Sung Lim, Ki Hak Song, Ju Hyun Shin, Jong Mok Park, Ji Yong Lee
- Int Neurourol J. 2024;28(1):52-58. Published online 2024 March 31
-
- The Comparative Effectiveness of Botulinum Toxin-A Injection Therapy Versus Augmentation Uretero-Enterocystoplasty for the Treatment of Lower Urinary Tract Dysfunction
- Xuesheng Wang, Zhonghan Zhou, Limin Liao
- Int Neurourol J. 2023;27(1):36-46. Published online 2023 March 31
-
- Endoscopic Botulinum Toxin Injection for Refractory Enuresis Based on Urodynamic Assessment
- Gyoohwan Jung, Young-Jae Im, Gwan Jang, Jun Kyo Suh, Kwanjin Park
- Int Neurourol J. 2021;25(3):236-243. Published online 2021 March 6
-
- Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
- Yuan-Hong Jiang, Sheng-Fu Chen, Hann-Chorng Kuo
- Int Neurourol J. 2020;24(4):301-312. Published online 2020 December 31
-
- Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection - A Multicenter Experience
- Vladimír Šámal, Jan Krhut, Vít Paldus, Jana Műllerová, Jan Mečl
- Int Neurourol J. 2020;24(1):59-65. Published online 2020 March 31
-
- Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
- M.A. Elbaset, Diaa-Eldin Taha, Ahmed S. El-Hefnawy, Mohamad H. Zahran, A.A Shokeir
- Int Neurourol J. 2019;23(3):240-248. Published online 2019 September 30
-
- Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
- Hamilton Trinh, Vicki Irish, Mireya Diaz, Humphrey Atiemo
- Int Neurourol J. 2019;23(3):226-233. Published online 2019 September 30
-
- Predictors of Nerve Stimulator Success in Patients With Overactive Bladder
- Kristian D. Stensland, Bennett Sluis, Jay Vance, Jared P. Schober, Lara S. MacLachlan, Arthur P. Mourtzinos
- Int Neurourol J. 2018;22(3):206-211. Published online 2018 September 28
-
- Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?
- Shannon HK Kim, David Habashy, Sana Pathan, Vincent Tse, Ruth Collins, Lewis Chan
- Int Neurourol J. 2016;20(1):40-46. Published online 2016 March 16
-
- Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
- Chun-Hou Liao, Hann-Chorng Kuo
- Int Neurourol J. 2015;19(4):213-219. Published online 2015 December 28
-
- Botulinum Toxin in Neurogenic Detrusor Overactivity
- Carlos Arturo Levi D'Ancona, Rúiter Silva Ferreira, Mauricio Carneiro Rassi
- Int Neurourol J. 2012;16(3):139-143. Published online 2012 September 30
-
| 1 | |
- Official Journal of Korean Continence Society & ESSIC (International Society for the Study of BPS) & Korean Society of Urological Research & The Korean Children’s Continence and Enuresis Society & The Korean Association of Urogenital Tract Infection and Inflammation & Korean Society of Geriatric Urological Care
- Editorial Office
-
Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine,
29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea
Tel: +82-2-2001-2237 Fax: +82-2-2001-2247 E-mail: support@einj.org
Copyright © 2025 by Korean Continence Society.
